Metropolitan Life Insurance CO Absci Corp Transaction History

Metropolitan Life Insurance CO

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jun 14, 2023	BUY	$2.0 - $3.58 $7,480 - $13,389	3,740 New	3,740 $7.85 Million
Q4 2022 Mar 30, 2023	SELL	$2.0 - $3.58 $438 - $784	-219 Reduced 5.53%	3,740 $7,000
Q4 2022 Feb 15, 2023	SELL	$2.0 - $3.58 $438 - $784	-219 Reduced 5.53%	3,740 $7,000
Q3 2022 Jun 14, 2023	BUY	$2.95 - $4.83 $11,679 - $19,121	3,959 New	3,959 $12.4 Million
Q2 2022 Jun 20, 2023	BUY	$3.13 - $8.83 $12,391 - $34,957	3,959 New	3,959 $13,000
Q1 2022 Jun 20, 2023	BUY	$5.87 - $9.46 $23,239 - $37,452	3,959 New	3,959 $33,000
Q1 2022 Mar 30, 2023	BUY	$5.87 - $9.46 $1,285 - $2,071	219 Added 5.86%	3,959 $33,000
Q1 2022 May 12, 2022	BUY	$5.87 - $9.46 $23,239 - $37,452	3,959 New	3,959 $33,000

128

59.3M

255K

93.6K

Ticker ABSI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 92,843,504
Market Cap $278M
Description
Absci Corporation, a drug and target discovery company, provides biologic drug candidates and production cell lines using integrated drug creation platform for partners in the United States. Its integrated drug creation platform enables the creation of biologics by unifying the drug discovery and cell line development processes into one process....

Get notified when there are updates to the investment portfolio of Metropolitan Life Insurance CO, based on Form 13F filings with the SEC.

Stay updated on Metropolitan Life Insurance CO with notifications on news.